BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28472632)

  • 1. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.
    Mouri A; Noda Y; Niwa M; Matsumoto Y; Mamiya T; Nitta A; Yamada K; Furukawa S; Iwamura T; Nabeshima T
    Behav Brain Res; 2017 Jun; 329():157-165. PubMed ID: 28472632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
    Koprich JB; Campbell NG; Lipton JW
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
    Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
    Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region-specific expression of brain-derived neurotrophic factor splice variants in morphine conditioned place preference in mice.
    Meng M; Zhao X; Dang Y; Ma J; Li L; Gu S
    Brain Res; 2013 Jun; 1519():53-62. PubMed ID: 23623815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement.
    Moreno-Sanz G; O'Shea E; Orio L; Escobedo I; González-Cuevas G; Navarro M; Colado MI; López-Moreno JA
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):929-40. PubMed ID: 19236733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
    Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
    Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.
    Trigo JM; Renoir T; Lanfumey L; Hamon M; Lesch KP; Robledo P; Maldonado R
    Biol Psychiatry; 2007 Sep; 62(6):669-79. PubMed ID: 17306775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
    Marona-Lewicka D; Rhee GS; Sprague JE; Nichols DE
    Pharmacol Biochem Behav; 1996 Jan; 53(1):99-105. PubMed ID: 8848466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice.
    Vidal-Infer A; Roger-Sánchez C; Daza-Losada M; Aguilar MA; Miñarro J; Rodríguez-Arias M
    PLoS One; 2012; 7(8):e43107. PubMed ID: 22916213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.
    Rodríguez-Arias M; Valverde O; Daza-Losada M; Blanco-Gandía MC; Aguilar MA; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():77-84. PubMed ID: 23959085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits.
    Abad S; Camarasa J; Pubill D; Camins A; Escubedo E
    Mol Neurobiol; 2016 Dec; 53(10):7271-7283. PubMed ID: 26687233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.
    Touriño C; Ledent C; Maldonado R; Valverde O
    Biol Psychiatry; 2008 Jun; 63(11):1030-8. PubMed ID: 17950256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.
    Zhang L; Shirayama Y; Shimizu E; Iyo M; Hashimoto K
    Eur J Pharmacol; 2006 Aug; 544(1-3):1-9. PubMed ID: 16859675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.
    Gudelsky GA; Yamamoto BK
    Pharmacol Biochem Behav; 2008 Aug; 90(2):198-207. PubMed ID: 18035407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term compulsive exercise reduces the rewarding efficacy of 3,4-methylenedioxymethamphetamine.
    Chen HI; Kuo YM; Liao CH; Jen CJ; Huang AM; Cherng CG; Su SW; Yu L
    Behav Brain Res; 2008 Feb; 187(1):185-9. PubMed ID: 17949827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
    Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of intravenous R,S-(+/-)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core.
    Acquas E; Pisanu A; Spiga S; Plumitallo A; Zernig G; Di Chiara G
    J Neurochem; 2007 Jul; 102(1):121-32. PubMed ID: 17564678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.
    White SR; Obradovic T; Imel KM; Wheaton MJ
    Prog Neurobiol; 1996 Aug; 49(5):455-79. PubMed ID: 8895996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour.
    Orejarena MJ; Lanfumey L; Maldonado R; Robledo P
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):927-40. PubMed ID: 20942998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.